Surgical Pathology Criteria

Superficial Myofibroblastoma

Supplemental Studies

Immunohistology

Desmin 88%
Smooth muscle actin 0-50%
CD34 50-80%
Estrogen receptor 90%
Progesterone receptor 100%

Stanford Medicine Resources:

Footer Links: